Impax Asset Management Group’s Health Catalyst HCAT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.4M | Hold |
2,750,000
| – | – | 0.06% | 138 |
|
|
2025
Q1 | $12.5M | Hold |
2,750,000
| – | – | 0.08% | 131 |
|
|
2024
Q4 | $19.4M | Buy |
2,750,000
+195,525
| +8% | +$1.38M | 0.09% | 125 |
|
|
2024
Q3 | $20.8M | Buy |
2,554,475
+360,201
| +16% | +$2.93M | 0.08% | 126 |
|
|
2024
Q2 | $14M | Buy |
2,194,274
+39,799
| +2% | +$254K | 0.06% | 140 |
|
|
2024
Q1 | $16.2M | Buy |
2,154,475
+400,000
| +23% | +$3.01M | 0.06% | 140 |
|
|
2023
Q4 | $16.2M | Buy |
1,754,475
+600,000
| +52% | +$5.56M | 0.07% | 132 |
|
|
2023
Q3 | $11.7M | Hold |
1,154,475
| – | – | 0.05% | 151 |
|
|
2023
Q2 | $14.4M | Sell |
1,154,475
-50,000
| -4% | -$625K | 0.06% | 140 |
|
|
2023
Q1 | $14.1M | Hold |
1,204,475
| – | – | 0.06% | 137 |
|
|
2022
Q4 | $12.8M | Buy |
1,204,475
+294,419
| +32% | +$3.13M | 0.06% | 143 |
|
|
2022
Q3 | $8.83M | Buy |
910,056
+100,000
| +12% | +$970K | 0.05% | 155 |
|
|
2022
Q2 | $11.7M | Buy |
810,056
+425,000
| +110% | +$6.16M | 0.06% | 141 |
|
|
2022
Q1 | $10.1M | Hold |
385,056
| – | – | 0.04% | 156 |
|
|
2021
Q4 | $15.3M | Buy |
385,056
+75,000
| +24% | +$2.97M | 0.06% | 137 |
|
|
2021
Q3 | $15.5M | Buy |
310,056
+75,000
| +32% | +$3.75M | 0.06% | 129 |
|
|
2021
Q2 | $13M | Buy |
235,056
+35,256
| +18% | +$1.96M | 0.06% | 131 |
|
|
2021
Q1 | $9.35M | Sell |
199,800
-200
| -0.1% | -$9.35K | 0.05% | 143 |
|
|
2020
Q4 | $8.71M | Hold |
200,000
| – | – | 0.06% | 127 |
|
|
2020
Q3 | $7.32M | Buy |
+200,000
| New | +$7.32M | 0.06% | 131 |
|